---
title: "PAVM.US (PAVM.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/PAVM.US/news.md"
symbol: "PAVM.US"
name: "PAVM.US"
parent: "https://longbridge.com/en/quote/PAVM.US.md"
datetime: "2026-05-20T17:14:39.044Z"
locales:
  - [en](https://longbridge.com/en/quote/PAVM.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PAVM.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PAVM.US/news.md)
---

# PAVM.US (PAVM.US) — Related News

### [Analyst Reaffirms Buy on PAVmed, Citing Oncology Platform Momentum and Partnerships; Price Target Maintained at $16](https://longbridge.com/en/news/286945953.md)
*2026-05-19T15:45:29.000Z*
> Analyst Anthony Vendetti from Maxim Group has reaffirmed a Buy rating on PAVmed, maintaining a price target of $16. He c

### [PAVmed Q1 2026 Earnings Call Transcript](https://longbridge.com/en/news/286580498.md)
*2026-05-15T14:11:07.000Z*
> PAVmed (NASDAQ:PAVM) reported a GAAP net loss of $1.1 million for Q1 2026, following a restructuring that improved its c

### [PAVmed Reports Q1 2026 Results and Business Update](https://longbridge.com/en/news/286567652.md)
*2026-05-15T12:29:16.000Z*
> PAVmed reported Q1 2026 results, highlighting a simplified capital structure and stronger balance sheet. The company adv

### [PAVmed | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 22 K](https://longbridge.com/en/news/286562396.md)
*2026-05-15T12:08:38.000Z*
### [12 Health Care Stocks Moving In Wednesday's Pre-Market Session](https://longbridge.com/en/news/285377120.md)
*2026-05-06T12:06:21.000Z*
> In Wednesday's pre-market session, Avalo Therapeutics (AVTX) saw a significant gain of 50.9%, reaching $24.53, while Glu

### [PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026 | LUCD Stock News](https://longbridge.com/en/news/284898079.md)
*2026-05-01T04:35:33.000Z*
> PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026 | LUCD Stock News

### [Lishan Aklog Discloses Investment at PAVmed Inc. with 5.1% Stake](https://longbridge.com/en/news/282268119.md)
*2026-04-10T01:06:00.000Z*
> Lishan Aklog, M.D., Chairman and CEO of PAVmed Inc., disclosed a 5.1% stake in the company’s common stock, as per a Sche